Latest Conference

A discussion about the Association for Professionals in Infection Control and Epidemiology with CEO Devin Jopp.

Screening and isolation protocols were shown to reduce the risk of transmission.

AFHs reported concerns such as staff coming to work sick and lack of PPE.

IPs experienced PPE shortages, high levels of stress and emotional exhaustion.

A study looked at the prevalence of Metallo-B-lactamase (MBLs) producing A. baumannii isolates in one hospital setting.

Staff trainings on prevention practices were found to be common by inconsistent.

The organizations and their full-time employees both benefited from the PRN IPs.

A significant decrease in the rate of VAP occurred during the study period.

Post-intervention saw 55% of patients receive overall guideline-concordant antibiotics.

The CAD demonstrated excellent sustained antiviral activity against the test pathogen.

Average annual discharges were significantly higher in participating hospitals.

Communal gathering areas were found to be a major source of exposure.

During the pandemic, one regional health system looked at the age distribution of the virus and hospitalization and mortality rates.

New ASM data show indoor environments are associated with quick and frequent pathogen contamination of the common respiratory device.

An interview with a study author on unique associations between county infrastructures and COVID-19 fatality rates.

New findings on an available 15-minute test show an approximate 81% sensitivity in detection of SARS-CoV-2.

New findings from the ASM 2021 World Microbe Forum suggest the emergency-authorized platform can capably detected the highly transmissible UK-borne variant.

A discussion on issues surrounding the treatment of HIV with Melissa Badowski, PharmD, MPH.

A conversation on antimicrobial stewardship with Kushal Naik, PharmD, MBA.

An investigational therapy demonstrated neutralizing antibodies as well as protection against the virus in preclinical trials.

A study looked at hospital admissions of Medicare patients and saw a large percentage of recurrent Clostridioides difficile infections (rCDI) as the primary diagnosis.

No difference was observed in any of the outcomes and there was no impact on the duration of therapy.

GDC and DSENS were both seen to be safe and effective tools to optimize therapy in the study participants.

An effort to increase stewardship showed that 5-day and 10-day prescription stop dates for antibiotics did little to influence actual therapy length and outcomes.

A diagnostic analyzer was studied looking at 3 biomarkers to predict the level of COVID-19, and could potentially serve as a risk stratification tool.

An assessment from the Cleveland Clinic shows prescribing concordant to guidelines can exceed 60% in certain facilities.

Almost half of the participants in the study had an opportunity to improve their antibiotic regimen.

The pilot program was demonstrated to significantly reduce days of antibiotic therapy.